Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Auryxia on ESA Utilization in ESRD Patients
NCT03055598Phase 4Active, not recruiting
- Start
- May 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric citrate in anemia of chronic kidney disease (CKD-A). Started May 2017; status: active, not recruiting.
02
Drugs
ferric citrate
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03055598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055598.